OpenAI's AI-powered chatbot ChatGPT’s rise in web traffic has propelled it past Elon Musk's X and Yahoo, making it the sixth most-visited website globally in January 2025.
What Happened: Last week, Similarweb posted its latest desktop traffic rankings for January 2025.
The latest rankings reveal that Alphabet Inc.'s GOOG GOOGL Google continues to dominate with a 29.21% traffic share, followed by YouTube at 20.40%.
Meta Platforms, Inc.'s META Facebook holds the third spot with 5.08%, while WhatsApp and Instagram are fourth and fifth, respectively.
ChatGPT follows closely with a 2.33% traffic share, showing a notable month-over-month increase of 5.91%.
X, formerly Twitter ranks seventh with a 1.92% traffic share, and Yahoo is eighth at 1.88%. Reddit Inc. RDDT and Netflix Inc. NFLX complete the top ten list.
Reacting to the ranking, OpenAI CEO Sam Altman took to X, and said, "Man, still a long way to go to run down Google."
Similarweb also revealed the top 10 apps in the U.S. (iPhone) in January: DeepSeek – AI Assistant, ChatGPT, Threads, Block Blast!, TurboTax: File Your Tax Return, T-Life, Google, Google Gemini, Flip: Watch, Create, Shop and Temu: Shop Like a Billionaire.
Subscribe to the Benzinga Tech Trends newsletter to get all the latest tech developments delivered to your inbox.
Why It’s Important: In December 2022, almost a month after ChatGPT had its public release, it was reported Google had declared a “code red,” seeing it posing a threat to its search dominance.
In October 2024, OpenAI further challenged Google by unveiling ChatGPT Search, enabling users to access real-time information, a feature traditionally dominated by search engines.
By December, OpenAI expanded this feature to all users, including those on the free tier, enhancing its accessibility and reach.
Meanwhile, Musk, who co-founded OpenAI and then left in 2018, has reportedly made a $97.4-billion bid to regain control of the company.
Photo by jamesonwu1972 on Shutterstock
Check out more of Benzinga's Consumer Tech coverage by following this link.
Read Next:
Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.